Diabetes Mellitus, Type 1: all 3,614 studies

Page 11 of 37. Open to participants first (585), then studies with results posted, then the rest; newest registration first within each.

• A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 DiabetesCompletedNCT02038764Phase 1Results posted
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCompletedNCT02034513Phase 3Results posted
• Tailored Diabetes Self-Management ResourcesCompletedNCT02024750Not applicableResults posted
• Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized GlucagonCompletedNCT02018627Phase 2/3Results posted
• Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus PatientsCompletedNCT02000817Phase 1/2Results posted
• A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCompletedNCT01999322Phase 3Results posted
• Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
• Safety Study of Repeated Doses of Glucagon on Animal Starch in the LiverCompletedNCT01986231Not applicableResults posted
• Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp StudyCompletedNCT01973413Not applicableResults posted
• Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 DaysCompletedNCT01969747Phase 2Results posted
• Closed Loop Control in Adolescents Using Heart Rate as Exercise IndicatorCompletedNCT01945060Not applicableResults posted
• Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 DiabetesTerminatedNCT01939834Not applicableResults posted
• A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I DiabetesCompletedNCT01928329Phase 2Results posted
• A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 DiabeticsCompletedNCT01925989Phase 1Results posted
• Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®TerminatedNCT01898286Phase 3Results posted
• A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic PatientsCompletedNCT01897688Phase 3Results posted
• Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in AdolescentsCompletedNCT01890954Not applicableResults posted
• Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 DiabetesCompletedNCT01883804Not applicableResults posted
• Metformin Therapy for Overweight Adolescents With Type 1 DiabetesCompletedNCT01881828Phase 3Results posted
• Medtronic Minimed Overnight Closed-Loop SystemCompletedNCT01881009Not applicableResults posted
• Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind CorpCompletedNCT01874392Not applicableResults posted
• Artificial Pancreas Control System in an Outpatient SettingCompletedNCT01871870Phase 2Results posted
• Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes MellitusCompletedNCT01868594Phase 4Results posted
• Overnight Closed Loop Study in U.S.CompletedNCT01857973Not applicableResults posted
• Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT01856790Early Phase 1Results posted
• CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT01848990Phase 4Results posted
• The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesCompletedNCT01836523Phase 3Results posted
• Biobehavioral Mechanisms of Glucose VariabilityCompletedNCT01835964Not applicableResults posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01835431Phase 3Results posted
• The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) TrialTerminatedNCT01834144Not applicableResults posted
• The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine PancreasCompletedNCT01833988Not applicableResults posted
• Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 DiabetesCompletedNCT01831765Phase 3Results posted
• Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in ChildrenCompletedNCT01823341Phase 2Results posted
• Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet TransplantationCompletedNCT01817959Phase 3Results posted
• Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 DiabetesCompletedNCT01816165Phase 3Results posted
• Effect of Metformin on Vascular and Mitochondrial Function in Type 1 DiabetesCompletedNCT01813929Phase 4Results posted
• EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 DiabetesCompletedNCT01808690Phase 3Results posted
• A Study of LY2605541 in Participants With Type 1 Diabetes MellitusCompletedNCT01792284Phase 3Results posted
• 52 Week Trial of Liraglutide in Type 1 DiabetesCompletedNCT01787916Phase 4Results posted
• A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 DiabetesCompletedNCT01784211Phase 1Results posted
• Imatinib Treatment in Recent Onset Type 1 Diabetes MellitusCompletedNCT01781975Phase 2Results posted
• Orchestra Pregnancy Observational Study in PolandCompletedNCT01779141Results posted
• Model Driven Diabetes CareCompletedNCT01774149Not applicableResults posted
• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1CompletedNCT01773707Phase 2Results posted
• A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 DiabetesCompletedNCT01771250Phase 1Results posted
• A Study of LY2605541 and Glargine in Participants With Type 1 DiabetesCompletedNCT01769404Phase 1Results posted
• Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine PancreasCompletedNCT01762059Not applicableResults posted
• Liraglutide Versus Insulin Mono-therapy in the Closed Loop SettingCompletedNCT01755416Phase 2Results posted
• Liraglutide In Overweight Patients With Type 1 DiabetesCompletedNCT01753362Phase 3Results posted
• Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes MellitusCompletedNCT01742208Phase 2Results posted
• An Outpatient Pump Shutoff Pilot Feasibility and Safety StudyCompletedNCT01736930Phase 2Results posted
• Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 DiabetesCompletedNCT01724190Not applicableResults posted
• Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 DiabetesCompletedNCT01722643Not applicableResults posted
• Liraglutide in the Treatment of Type 1 Diabetes MellitusCompletedNCT01722266Phase 3Results posted
• Liraglutide in Type 1 DiabetesCompletedNCT01722240Phase 3Results posted
• Registry of Use and Application of Sensor Augmented Pump (SAP) Therapy Under Daily Life ConditionsCompletedNCT01718522Results posted
• Early Feasibility Study 2 of Outpatient Control-to-Range - Testing System EfficacyCompletedNCT01714505Not applicableResults posted
• Effects of Micronutrient (Chromium) Supplementation on DiabetesCompletedNCT01709123Not applicableResults posted
• Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic ProfilingCompletedNCT01684943Not applicableResults posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT01683266Phase 3Results posted
• Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume CombinationsCompletedNCT01680328Phase 1Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01658579Phase 2Results posted
• A Study of LY2605541 Versus Insulin Glargine on Blood SugarCompletedNCT01654380Phase 1Results posted
• Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 DiabetesCompletedNCT01653210Results posted
• Study of LY2409021 in Participants With Type 1 DiabetesCompletedNCT01640834Phase 1Results posted
• Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes MellitusTerminatedNCT01603121Phase 1/2Results posted
• A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCompletedNCT01600950Phase 1Results posted
• Outpatient Pump Shutoff Pilot Feasibility and Efficacy StudyCompletedNCT01591681Phase 2Results posted
• Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 DiabetesCompletedNCT01586065Not applicableResults posted
• Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise MarkerCompletedNCT01582139Not applicableResults posted
• Outpatient Control-to-Range: System and Monitoring TestingCompletedNCT01578980Not applicableResults posted
• A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 DiabetesCompletedNCT01569841Phase 3Results posted
• Artificial Pancreas Control System in an Inpatient SettingCompletedNCT01552603Phase 2Results posted
• New Strategies for Postprandial Glycemic Control Using Insulin Pump TherapyCompletedNCT01550809Phase 3Results posted
• Clinical Assessment of a Closed-loop Insulin Delivery SystemCompletedNCT01534013Not applicableResults posted
• Sitagliptin Dose Determination StudyCompletedNCT01530178Phase 4Results posted
• Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human HyaluronidaseCompletedNCT01526733Phase 4Results posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01513473Phase 3Results posted
• BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 DiabetesCompletedNCT01498185Phase 2Results posted
• Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend FeatureCompletedNCT01497938Phase 3Results posted
• Medtronic Treat to Range (TTR) Closed-Loop ControlCompletedNCT01490151Not applicableResults posted
• Physiologic Response to Glucagon at Varying Insulin LevelsCompletedNCT01483651Not applicableResults posted
• REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)CompletedNCT01483560Phase 3Results posted
• Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I DiabetesCompletedNCT01483352Not applicableResults posted
• A Study in Participants With Type 1 Diabetes MellitusCompletedNCT01481779Phase 3Results posted
• Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral NeuropathyCompletedNCT01480297Phase 2Results posted
• Glucose Counterregulation in Long Standing Type 1 DiabetesCompletedNCT01474889Not applicableResults posted
• A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)CompletedNCT01469715Phase 2Results posted
• Glutamine and Insulin Sensitivity in Type I DiabetesCompletedNCT01467063Not applicableResults posted
• A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of UseCompletedNCT01464346Not applicableResults posted
• ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?CompletedNCT01460446Not applicableResults posted
• A Study in Participants With Type I Diabetes MellitusCompletedNCT01454284Phase 3Results posted
• Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment PeriodCompletedNCT01445951Phase 3Results posted
• Insulin Sensitivity, Impaired Counterregulation, and Glucose VariabilityCompletedNCT01439672Not applicableResults posted
• Development of a Behavioral Observer for Type 1 Diabetes MellitusCompletedNCT01434030Not applicableResults posted
• A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes MellitusCompletedNCT01421355Phase 1Results posted
• Closed-Loop Insulin Delivery in Children Less Than 7 Years of AgeCompletedNCT01421225Not applicableResults posted
• A Study in Adults With Type 1 DiabetesCompletedNCT01421147Phase 3Results posted
• Feasibility Study of a Modular Control to Range System in Type 1 Diabetes MellitusCompletedNCT01418703Not applicableResults posted

← Diabetes Mellitus, Type 1 overview